* Additional details on other secondary outcomes other than the change in body weight can be found at as NCT03954834 (SURPASS-1), NCT03987919 (SURPASS-2), NCT03882970 (SURPASS-3), NCT03730662 (SURPASS-4), NCT04039503 (SURPASS-5), NCT04537923 (SURPASS-6), NCT04255433 (SURPASS-CVOT), NCT03861052(SURPASS J-mono), NCT04093752 (SURPASS-AP-Combo), and NCT04184622 (SURMOUNT-1)
After three or more missed weeks, consider a more conservative re-titration starting two tiers below maintenance
And when they get too short, the cell stops dividing entirely
The pattern tells the story
However, both medications can affect appetite, mood, and metabolic processes through different mechanisms
No specific result, amount of weight loss, improvement, or treatment outcome is guaranteed